Faeth Therapeutics, Inc. ($FTH)
Filing Information
| Accession Number | 0001780030-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 24, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
17,413
Total Value
$405,920.62
P&L
+5.3% (+$21,394.40)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Purchase | 1,797 | $20.23 | $36,353.31 | 1,797 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Purchase | 1,118 | $20.82 | $23,276.76 | 2,915 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Purchase | 1,583 | $22.40 | $35,459.20 | 4,498 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Purchase | 3,329 | $23.28 | $77,499.12 | 7,827 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 22, 2026 | Purchase | 356 | $23.95 | $8,526.20 | 8,183 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 23, 2026 | Purchase | 6,836 | $24.12 | $164,884.32 | 15,019 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 23, 2026 | Purchase | 1,969 | $24.84 | $48,909.96 | 16,988 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 23, 2026 | Purchase | 425 | $25.91 | $11,011.75 | 17,413 | Indirect | See footnote | View Details |